Full Press Release Details
INDIANAPOLIS , July 1, 2011 /PRNewswire/ -- Fionnuala Walsh , Ph.D., will join the executive committee of Eli Lilly and Company (NYSE: LLY ) on July 1 .
Walsh will continue in her current role as Lilly's senior vice president of global quality, reporting to John Lechleiter , Ph.D., chairman, president, and CEO, and working to ensure Lilly continues to maintain high quality standards across its worldwide operations.
Walsh is a recognized thought leader in the quality industry, often speaking about Lilly's sustainable, integrated quality system and the company's commitment to maintaining a quality culture. Her presence on the company's most senior governance committee is expected to further underscore Lilly's ongoing commitment to quality.
A native of Ireland , Walsh earned a bachelor's degree and doctoral degree in chemistry from University College Dublin. She joined Lilly's Kinsale, Ireland , manufacturing site in 1988 as a technical services chemist. After numerous positions there, she moved into a role as global quality leader at the Lilly Corporate Center in Indianapolis in 2002.
In January 2003 , Walsh was named executive director of quality for U.S. drug product and Lilly Technology Center operations. In July 2005 , she was named vice president of global quality operations, and, in June 2007 , she was named senior vice president of global quality.
About Eli Lilly and Company
Lilly, a leading, innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind. , Lilly provides answers—through medicines and information – for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com . C-LLY
SOURCE Eli Lilly and Company